The global advanced therapeutics market is rapidly evolving, fueled by technological advancements and the increasing prevalence of chronic and genetic diseases. The demand for cutting-edge therapies such as gene therapy, CAR-T cell therapy, and RNA-based treatments is growing, particularly in oncology, genetic disorders, and neurological diseases. For instance, the global incidence of cancer is expected to reach 28.4 million cases by 2040, as per the World Health Organization (WHO), which underscores the critical need for novel treatments. Additionally, rare diseases, affecting millions worldwide with over 7,000 recognized conditions, continue to drive interest in advanced therapeutics, as these conditions often lack effective treatment options. The increasing focus on personalized medicine, where treatments are tailored to individual genetic profiles, is also contributing to market expansion, with significant investment in research and clinical trials aimed at developing more effective and targeted therapies for diverse patient populations.
